Suppr超能文献

甲状腺激素模拟物:在动脉粥样硬化、肥胖症和2型糖尿病中的潜在应用。

Thyroid hormone mimetics: potential applications in atherosclerosis, obesity and type 2 diabetes.

作者信息

Baxter John D, Webb Paul

机构信息

Methodist Hospital Research Institute, F8-044 6565 Fannin, Houston, Texas 77030, USA.

出版信息

Nat Rev Drug Discov. 2009 Apr;8(4):308-20. doi: 10.1038/nrd2830.

Abstract

Thyroid hormones influence heart rate, serum lipids, metabolic rate, body weight and multiple aspects of lipid, carbohydrate, protein and mineral metabolism. Although increased thyroid hormone levels can improve serum lipid profiles and reduce fat, these positive effects are counterbalanced by harmful effects on the heart, muscle and bone. Thus, attempts to use thyroid hormones for cholesterol-lowering and weight loss purposes have so far been limited. However, over the past decade, thyroid hormone analogues that are capable of uncoupling beneficial effects from deleterious effects have been developed. Such drugs could serve as powerful new tools to address two of the largest medical problems in developed countries--atherosclerosis and obesity.

摘要

甲状腺激素会影响心率、血脂、代谢率、体重以及脂质、碳水化合物、蛋白质和矿物质代谢的多个方面。虽然甲状腺激素水平升高可改善血脂状况并减少脂肪,但这些积极作用会被其对心脏、肌肉和骨骼的有害作用所抵消。因此,迄今为止,试图使用甲状腺激素来降低胆固醇和减肥的尝试受到了限制。然而,在过去十年中,已经开发出了能够将有益作用与有害作用分离的甲状腺激素类似物。这类药物可能成为解决发达国家两个最大医学问题——动脉粥样硬化和肥胖症的有力新工具。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验